1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET BY TYPE
5.1. Introduction
5.2. Hemodialysis
5.3. Peritoneal dialysis
6. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET BY PRODUCT
6.1. Introduction
6.2. Device
6.3. Consumables
7. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET BY END-USER
7.1. Introduction
7.2. Home-based
7.3. Hospital-based
8. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. The Renal Project
10.2. DaVita
10.3. Fresenius Kidney Care
10.4. NephroPlus
10.5. NxStage
10.6. Mayo Clinic
10.7. NephCure
10.8. Fresenius
10.9. Cleveland Clinic
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES